NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib

Ibrahim Hamza Kankia, Hilal S. Khalil, Simon P. Langdon, Peter R. Moult, James L. Bown, Yusuf Y. Deeni^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review